Natarajan Ganesan

Disruption of transforming growth factor-β signaling through β-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation

Krit Kitisin, Natarajan Ganesan, Yamei Tang et al. · Oncogene · 2007 · 109 citations · Full text

Cancer Research, Signal Transduction, Signaling Pathway +13

Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon

Thanemozhi G. Natarajan, Bhaskar Kallakury, Christine E. Sheehan et al. · Cancer Cell International · 2010 · 52 citations · Full text

Increased DNA-binding activity of cis-1,1-cyclobutanedicarboxylatodiammineplatinum(II) (carboplatin) in the presence of nucleophiles and human breast cancer MCF-7 cell cytoplasmic extracts: activation theory revisited

Natarajan Ganesan, R. Malathi, Eggehard Holler · Biochemical Pharmacology · 1999 · 40 citations

Breast Oncology, Medicine, Molecular Biology +9

Gold layer-based dual crosslinking procedure of glucose oxidase with ferrocene monocarboxylic acid provides a stable biosensor

Natarajan Ganesan, Anand Gadre, Makarand Paranjape et al. · Analytical Biochemistry · 2005 · 21 citations

Ferrocene Monocarboxylic Acid, Biochemistry, Bioelectrochemistry +6

γ-Radiation-Induced Chromosomal Mutagen Sensitivity Is Associated with Breast Cancer Risk in African-American Women: Caffeine Modulates the Outcome of Mutagen Sensitivity Assay

Thanemozhi G. Natarajan, Natarajan Ganesan, Pamela L. Carter-Nolan et al. · Cancer Epidemiology Biomarkers & Prevention · 2006 · 18 citations